• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS INC. ADVIA CHEMISTRY HBA1C DENATURANT REAGENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS INC. ADVIA CHEMISTRY HBA1C DENATURANT REAGENT Back to Search Results
Model Number ADVIA CHEMISTRY HBA1C DENATURANT REAGENT
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 10/28/2014
Event Type  malfunction  
Event Description
The customer has obtained discordant results on seventy three patient samples for the a1c3 assay on an advia chemistry 2400 instrument when using reagent lot 170.Quality control and slope adjustments for the assay were within specifications the day the samples were run.Results of seventy three patient samples were reported to physician(s).The samples were also run on an alternate platform and the results were lower.There were no reports of adverse health consequences due to the high a1c3 results on the patient samples.
 
Manufacturer Narrative
A siemens headquarters support center (hsc) representative has evaluated the patient data.The cause of the high results for a1c3 when using reagent lot 170 is unknown.Siemens diagnostics is investigating the issue.
 
Manufacturer Narrative
The initial mdr 2432235-2014-00703 was filed on december 4, 2014.Additional information (05/06/15): siemens technical operations investigated the issue which was reviewed on 5/6/15, where internal studies and testing on reagent lot 170 returned by the customer, showed no discordant patient results.Quality control samples and whole blood samples with assigned target values were tested with reagent lot 170 and recovered as per specifications.Additional information (5/8/2015): siemens headquarters support center (hsc) contacted the customer, and were informed on 5/8/15 that the customer had moved on to a different reagent lot and has had no problems.The cause of the falsely high results on patient samples for hemoglobin a1c_3 is unknown.The instrument is performing according to specifications.No further evaluation of the device is required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CHEMISTRY HBA1C DENATURANT REAGENT
Type of Device
ADVIA CHEMISTRY HBA1C DENATURANT REAGENT
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
511 benedict avenue
tarrytown NY 10591
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS (REG# 2517506)
500 gbc drive
p.o. box 6101
newark DE 19714 6101
Manufacturer Contact
aarti aziz
511 benedict avenue
tarrytown, NY 10591
9145242683
MDR Report Key4296333
MDR Text Key5058582
Report Number2432235-2014-00703
Device Sequence Number1
Product Code LCP
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
K081895
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,foreign,health profe
Reporter Occupation Health Professional
Type of Report Initial
Report Date 11/07/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/04/2014
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Model NumberADVIA CHEMISTRY HBA1C DENATURANT REAGENT
Device Catalogue Number10286032
Device Lot Number170
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/06/2015
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-